Mucopurulent Cervicitis: Term for an Irritated Cervix
The medical term for an irritated cervix is "cervicitis," specifically "mucopurulent cervicitis" when characterized by inflammation with purulent or mucopurulent discharge from the endocervical canal. 1
Diagnostic Characteristics
Cervicitis is defined by two major diagnostic signs:
- Purulent or mucopurulent endocervical exudate visible in the endocervical canal or on an endocervical swab specimen
- Sustained endocervical bleeding easily induced by gentle passage of a cotton swab through the cervical os 1
Either or both signs may be present. Additional findings may include:
- Abnormal vaginal discharge
- Intermenstrual vaginal bleeding (especially post-coital)
- Leukorrhea (>10 WBC per high power field on microscopic examination of vaginal fluid) 1
Etiology
Cervicitis is most commonly caused by:
Infectious agents:
Other potential causes:
- Mycoplasma genitalium
- Bacterial vaginosis
- Frequent douching
- Chemical irritants
- Idiopathic inflammation in the zone of ectopy 1
In many cases (particularly in women over 30 years), no specific organism is isolated despite testing 1.
Diagnostic Approach
When cervicitis is suspected, the following tests are recommended:
- Nucleic Acid Amplification Tests (NAATs) for C. trachomatis and N. gonorrhoeae (most sensitive and specific tests) 1, 3
- Evaluation for bacterial vaginosis and trichomoniasis 1
- For symptomatic women with negative microscopy for trichomonads, further testing (culture or antigen-based detection) 1
- Visual examination for purulent/mucopurulent discharge and easily induced bleeding 3
Clinical Significance
Cervicitis requires proper diagnosis and treatment because:
- It may be a sign of upper genital tract infection (endometritis or PID)
- Untreated infections can lead to serious complications including:
- In pregnant women, infections are associated with premature rupture of membranes and increased fetal morbidity 4
Treatment Approach
Treatment depends on the identified cause:
For confirmed or suspected chlamydial cervicitis:
For gonococcal cervicitis:
- Follow current CDC guidelines for gonorrhea treatment
For persistent cervicitis (after negative testing for common STIs):
Follow-up Recommendations
- Patients should abstain from sexual activity for 7 days after treatment initiation and until all partners are treated 3
- Routine test-of-cure is not recommended if symptoms resolve 3
- Consider retesting 3-12 months after treatment due to high risk of reinfection 3
- All sexual partners from the past 60 days should be notified, evaluated, and treated 3
Important Caveats
- Cervicitis is frequently asymptomatic but can still cause upper genital tract complications 2, 5
- No single risk factor reliably predicts infection, making screening important in high-risk populations 4
- "Normal vaginal flora" are rarely responsible for cervicitis, but should be considered as potential pathogens when tests for routine pathogens are negative 7
- Chronic nongonococcal nonchlamydial cervicitis can be particularly challenging to treat and may require multiple treatment approaches 6